JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB220161

Anti-YTHDF3 antibody [EPR21912-3]

  • RabMAb
  • Recombinant
  • KO Validated
  • 20ul selling size
  • What is this?

5

(3 Reviews)

|

(39 Publications)

Rabbit Recombinant Monoclonal YTHDF3 antibody. Suitable for IP, WB, IHC-Fr, Flow Cyt (Intra), IHC-P and reacts with Human, Mouse, Rat samples. Cited in 39 publications.

View Alternative Names

YTH domain-containing family protein 3, DF3, YTHDF3

11 Images
Flow Cytometry (Intracellular) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)

Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol permeabilized HeLa (human cervix adenocarcinoma epithelial cell) cell line labeling YTHDF3 with ab220161 at 1/60 (red) compared with a Rabbit monoclonal IgG (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077), at 1/2000 dilution was used as the secondary antibody.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)

Immunohistochemical analysis of paraffin-embedded human colon tissue labeling YTHDF3 with ab220161 at 1/100 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Cytoplasmic staining on human colon (PMID : 29103884, 28250115) is observed. Counterstained with hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).

Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

Immunoprecipitation - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)
  • IP

Unknown

Immunoprecipitation - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)

YTHDF3 was immunoprecipitated from 0.35 mg HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate with ab220161 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab220161 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used at 1/5000 dilution.

Lane 1 : HeLa whole cell lysate 10 μg (Input).
Lane 2 : ab220161 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab220161 in HeLa whole cell lysate.

Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 15 seconds.

Lysate were made freshly and used in IP test immediately to minimize protein degradation. Incubation time was 2h.

All lanes:

Immunoprecipitation - Anti-YTHDF3 antibody [EPR21912-3] (ab220161)

Predicted band size: 64 kDa

Observed band size: 73 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)

Immunohistochemical analysis of paraffin-embedded mouse cerebrum tissue labeling YTHDF3 with ab220161 at 1/500 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Cytoplasmic staining on neurons of mouse cerebrum (PMID : 29103884, 28250115) is observed. Counterstained with hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).

Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)

Immunohistochemical analysis of paraffin-embedded rat cerebrum tissue labeling YTHDF3 with ab220161 at 1/500 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Cytoplasmic staining on neurons of rat cerebrum (PMID : 29103884, 28250115) is observed. Counterstained with hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).

Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)
  • IHC-P

AbReview71386****

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)

Immunohistochemistry analysis (Formalin/PFA-fixed paraffin-embedded sections) of paraformaldehyde-fixed mouse ovary tissue permeabilized with PBST (0.5% Triton X-100 in PBS). Stained with ab220161 at 1/200 dilution. Secondary antibody used was Alex Fluor 555 donkey anti-rabbit IgG at 1/500 dilution. Blocking was done with 5% BSA in PBST (0.1% tween in PBS) for 1 hour 30 minutes at 25°C. The sample was incubated with the primary antibody and 5% BSA in PBST (0.1% tween in PBS) for 12 hours at 4°C. Antigen retrieval method was heat mediated, Citrate antigen repair solution.

This image is courtesy of an Abreview submitted by Bin Shen

Immunohistochemistry (Frozen sections) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)
  • IHC-Fr

Unknown

Immunohistochemistry (Frozen sections) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)

Immunohistochemical analysis of 4% PFA-fixed, 0.2% Triton X-100 permeabilized frozen mouse cerebrum tissue labeling YTHDF3 with ab220161 at 1/100 dilution (green), followed by ab150077 AlexaFluor®488 Goat anti-Rabbit secondary at a 1/1,000 dilution. Cytoplasmic and nuclear staining in mouse cerebrum (PMID : 29103884, 28250115) is observed. Counterstained with DAPI (blue).

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is ab150077 AlexaFluor®488 Goat anti-Rabbit used at a 1/1,000 dilution.

Heat mediated antigen retrieval using sodium citrate buffer (10 mM citrate pH 6.0 and 0.05% Tween-20).

Immunohistochemistry (Frozen sections) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)
  • IHC-Fr

Unknown

Immunohistochemistry (Frozen sections) - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)

Immunohistochemical analysis of 4% PFA-fixed, 0.2% Triton X-100 permeabilized frozen rat cerebrum tissue labeling YTHDF3 with ab220161 at 1/100 dilution (green), followed by ab150077 AlexaFluor®488 Goat anti-Rabbit secondary at a 1/1,000 dilution. Cytoplasmic and nuclear staining in rat cerebrum (PMID : 29103884, 28250115) is observed. Counterstained with DAPI (blue).

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is ab150077 AlexaFluor®488 Goat anti-Rabbit used at a 1/1,000 dilution.

Heat mediated antigen retrieval using sodium citrate buffer (10 mM citrate pH 6.0 and 0.05% Tween-20).

Western blot - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)
  • WB

Unknown

Western blot - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)

Lysate should be made freshly and used in WB immediately to minimize protein degradation (lane1-4). Lane 5-7 are the lysates from same cell lines but have experienced freeze-thaw cycles.

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure times : Lanes 1-4 : 37 secs; Lanes 5-7 : 92 secs.

All lanes:

Western blot - Anti-YTHDF3 antibody [EPR21912-3] (ab220161) at 1/1000 dilution

Lane 1:

HT-1080 (human fibrosarcoma epithelial cell) whole cell lysate (fresh lysate) at 20 µg

Lane 2:

HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate (fresh lysate) at 20 µg

Lane 3:

NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (fresh lysate) at 20 µg

Lane 4:

PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate (fresh lysate) at 20 µg

Lane 5:

HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lane 6:

NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg

Lane 7:

PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 64 kDa

false

Western blot - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)
  • WB

Unknown

Western blot - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)

The wild-type and YTHDF3 knockout cell lysates were kindly provided by an anonymous collaborator.

ab220161 was shown to specifically react with YTHDF3 in wild-type mESC cells as signal was lost in YTHDF3 knockout cells. Wild-type and YTHDF3 knockout samples were subjected to SDS-PAGE. ab220161 and ab181602 (Rabbit anti-GAPDH loading control) were incubated 1 hour at room temperature at 1/1000 dilution and 1/200,000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary antibody at 1/100,000 dilution for 1 hour at room temperature before imaging.

The blot was developed on a BIO-RAD® ChemiDoc™ MP instrument using the ECL technique.

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-YTHDF3 antibody [EPR21912-3] (ab220161) at 1/1000 dilution

Lane 1:

Wild-type mESC (mouse embryo stem cell) whole cell lysate at 20 µg

Lane 2:

YTHDF3 knockout mESC whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 64 kDa

Observed band size: 73 kDa

false

Exposure time: 59s

Western blot - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)
  • WB

Unknown

Western blot - Anti-YTHDF3 antibody [EPR21912-3] (AB220161)

The YTHDF recombinant proteins were kindly provided by an anonymous collaborator.

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-YTHDF3 antibody [EPR21912-3] (ab220161) at 1/5000 dilution

Lane 1:

GST-tagged human YTHDF1 recombinant protein 20 ng

Lane 2:

GST-tagged human YTHDF2 recombinant protein 20 ng

Lane 3:

GST-tagged human YTHDF3 recombinant protein 20 ng

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 64 kDa

false

Exposure time: 10s

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR21912-3

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, IHC-P, IHC-Fr, Flow Cyt (Intra), IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCFr" : {"fullname" : "Immunohistochemistry (Frozen sections)", "shortname":"IHC-Fr"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCFr-species-checked": "guaranteed", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/60", "FlowCytIntra-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p>Use at 1/500 (mouse, rat) and 1/100 (human) dilution.</p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Mouse": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCFr-species-checked": "testedAndGuaranteed", "IHCFr-species-dilution-info": "1/100", "IHCFr-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p>Use at 1/500 (mouse, rat) and 1/100 (human) dilution.</p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Rat": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCFr-species-checked": "testedAndGuaranteed", "IHCFr-species-dilution-info": "1/100", "IHCFr-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p>Use at 1/500 (mouse, rat) and 1/100 (human) dilution.</p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The YTH domain family protein 3 (YTHDF3) is an m6A reader protein known also as YTH3 or YTHDF2-like protein 3. Its molecular weight is approximately 64 kDa. YTHDF3 plays a role in the recognition of N6-methyladenosine (m6A)-modified RNA an important post-transcriptional modification. It commonly expresses in various tissues including the brain liver and kidney indicating its involvement in multiple cellular processes. YTHDF3 binds to m6A-modified mRNA influencing the stability and translation of these molecules and interacts with other members of the YTH family.
Biological function summary

YTHDF3 facilitates the process of mRNA metabolism by participating in the regulation of mRNA translation and degradation. It functions as part of a dynamic complex with YTHDF1 and YTHDF2 coordinating the fate of m6A-modified mRNAs. YTHDF3 supports mRNA decay in synergy with YTHDF2 and enhances translation efficiency in cooperation with YTHDF1. This involvement in regulating gene expression at the post-transcriptional level equips cells to respond rapidly to various stimuli aligning gene expression with cellular needs.

Pathways

YTHDF3 significantly impacts RNA processing and metabolism pathways. YTHDF3 together with YTHDF1 and YTHDF2 modulates the m6A-mediated mRNA decay pathway. It holds functional significance in the cellular response to stress and adaptations in energy metabolism. YTHDF3 interacts closely with proteins such as IGF2BP1 alongside the YTHDF proteins which are critical in maintaining RNA stability and translation thereby illustrating its role across significant cellular pathways.

YTHDF3 has implications in cancer and neurodegenerative diseases. High YTHDF3 expression associates with various cancer types including gliomas and breast cancer where it can influence tumor growth and metastasis. In neurodegenerative diseases such as Alzheimer's disease YTHDF3 interacts with proteins like YTHDF1 and YTHDF2 affecting RNA metabolism in neurons contributing potentially to the pathology of these disorders. Through these interactions YTHDF3 could impact disease progression and outcomes making it a target of interest in therapeutic research.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs, and regulates their stability (PubMed : 28106072, PubMed : 28106076, PubMed : 28281539, PubMed : 32492408). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in mRNA stability and processing (PubMed : 22575960, PubMed : 24284625, PubMed : 28106072, PubMed : 28281539, PubMed : 32492408). Acts as a regulator of mRNA stability by promoting degradation of m6A-containing mRNAs via interaction with the CCR4-NOT complex or PAN3 (PubMed : 32492408). The YTHDF paralogs (YTHDF1, YTHDF2 and YTHDF3) share m6A-containing mRNAs targets and act redundantly to mediate mRNA degradation and cellular differentiation (PubMed : 28106072, PubMed : 28106076, PubMed : 32492408). Acts as a negative regulator of type I interferon response by down-regulating interferon-stimulated genes (ISGs) expression : acts by binding to FOXO3 mRNAs (By similarity). Binds to FOXO3 mRNAs independently of METTL3-mediated m6A modification (By similarity). Can also act as a regulator of mRNA stability in cooperation with YTHDF2 by binding to m6A-containing mRNA and promoting their degradation (PubMed : 28106072). Recognizes and binds m6A-containing circular RNAs (circRNAs); circRNAs are generated through back-splicing of pre-mRNAs, a non-canonical splicing process promoted by dsRNA structures across circularizing exons (PubMed : 28281539). Promotes formation of phase-separated membraneless compartments, such as P-bodies or stress granules, by undergoing liquid-liquid phase separation upon binding to mRNAs containing multiple m6A-modified residues : polymethylated mRNAs act as a multivalent scaffold for the binding of YTHDF proteins, juxtaposing their disordered regions and thereby leading to phase separation (PubMed : 31292544, PubMed : 31388144, PubMed : 32451507). The resulting mRNA-YTHDF complexes then partition into different endogenous phase-separated membraneless compartments, such as P-bodies, stress granules or neuronal RNA granules (PubMed : 31292544). May also recognize and bind N1-methyladenosine (m1A)-containing mRNAs : inhibits trophoblast invasion by binding to m1A-methylated transcripts of IGF1R, promoting their degradation (PubMed : 32194978).. Has some antiviral activity against HIV-1 virus : incorporated into HIV-1 particles in a nucleocapsid-dependent manner and reduces viral infectivity in the next cycle of infection (PubMed : 32053707). May interfere with this early step of the viral life cycle by binding to N6-methyladenosine (m6A) modified sites on the HIV-1 RNA genome (PubMed : 32053707).
See full target information YTHDF3

Publications (39)

Recent publications for all applications. Explore the full list and refine your search

Virus research 358:199590 PubMed40480313

2025

Enterovirus 71 structural viral protein 1 promotes the expression of PMP22 through mA modification in mouse Schwann cells.

Applications

Unspecified application

Species

Unspecified reactive species

Qiuyan Peng,Guangming Liu,Danping Zhu,Suyun Li,Sida Yang,Peiqing Li,Yingxian Yin,Dandan Hu

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 28:760-775 PubMed40366509

2025

The RNA-binding protein YTHDF3 affects gastric cancer cell migration and response to paclitaxel by regulating EZRIN.

Applications

Unspecified application

Species

Unspecified reactive species

Patrícia Mesquita,Alexandre Coelho,Ana S Ribeiro,Luís F C Póvoas,Catarina de Oliveira,Nelson Leça,Sara Silva,Diana Ferreira,Diana Pádua,Ricardo Coelho,Carmen Jerónimo,Joana Paredes,Carlos Conde,Bruno Pereira,Raquel Almeida

Genes & diseases 12:101327 PubMed40092485

2025

YTHDF1 shapes immune-mediated hepatitis via regulating inflammatory cell recruitment and response.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Li,Kailun Yu,Xiandan Zhang,Jiawen Li,Huilong Hu,Xusheng Deng,Siyu Zeng,Xiaoning Dong,Junru Zhao,Yongyou Zhang

Cell death discovery 10:320 PubMed38992016

2024

YTH domain family protein 3 accelerates non-small cell lung cancer immune evasion through targeting CD8 T lymphocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Yisheng Luo,Chao Zeng,Zezhong Ouyang,Wenbin Zhu,Jiazhi Wang,Zhiyin Chen,Chunyang Xiao,Guodong Wu,Liang Li,Youhui Qian,Xin Chen,Yuchen Liu,Hao Wu

BMC biology 22:104 PubMed38702712

2024

GnRH-driven FTO-mediated RNA mA modification promotes gonadotropin synthesis and secretion.

Applications

Unspecified application

Species

Unspecified reactive species

Hao-Qi Wang,Yi-Ran Ma,Yu-Xin Zhang,Fan-Hao Wei,Yi Zheng,Zhong-Hao Ji,Hai-Xiang Guo,Tian Wang,Jia-Bao Zhang,Bao Yuan

Biotechnology journal 19:e2400078 PubMed38651251

2024

Overexpression of YTHDF3 increases the specific productivity of the recombinant protein in CHO cells by promoting the translation process.

Applications

Unspecified application

Species

Unspecified reactive species

Zhao-Ming Cui,Ying-Ying Feng,Yan-Ping Gao,Hai-Tong Wang,Jiang-Tao Lu,Jia-Liang Guo,Hong-Yan Xu,Le-le Qiu,Tian-Yun Wang,Yan-Long Jia

Human genomics 18:33 PubMed38566168

2024

Profiling the role of m6A effectors in the regulation of pluripotent reprogramming.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjun Wang,Lei Zhou,Hui Li,Tingge Sun,Xue Wen,Wei Li,Miguel A Esteban,Andrew R Hoffman,Ji-Fan Hu,Jiuwei Cui

Epigenetics 19:2326868 PubMed38465865

2024

m6A reader YTHDC2 mediates NCOA4 mRNA stability affecting ferritinophagy to alleviate secondary injury after intracerebral haemorrhage.

Applications

Unspecified application

Species

Unspecified reactive species

Fengfeng Li,Fang Wang,Lei Wang,Jianhua Wang,Shanshan Wei,Junjun Meng,Yanan Li,Lei Feng,Pei Jiang

Cell proliferation 57:e13619 PubMed38444279

2024

YTHDF1 mediates N-methyl-N-nitrosourea-induced gastric carcinogenesis by controlling HSPH1 translation.

Applications

Unspecified application

Species

Unspecified reactive species

Peng Song,Xiang Li,Shuai Chen,Yu Gong,Jie Zhao,Yuwen Jiao,Yi Dai,Haojun Yang,Jun Qian,Yuan Li,Jian He,Liming Tang

Cell stem cell 30:1658-1673.e10 PubMed38065069

2023

SON is an essential mA target for hematopoietic stem cell fate.

Applications

Unspecified application

Species

Unspecified reactive species

Hanzhi Luo,Mariela Cortés-López,Cyrus L Tam,Michael Xiao,Isaac Wakiro,Karen L Chu,Aspen Pierson,Mandy Chan,Kathryn Chang,Xuejing Yang,Daniel Fecko,Grace Han,Eun-Young Erin Ahn,Quaid D Morris,Dan A Landau,Michael G Kharas
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com